American International Group’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

American International Group’s Portfolio NBSE Stock Details NBSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-489	Closed	-$72	–	3310
2021 Q1	$72	Buy	489 +1	+0.2%	+$181	﹤0.01%	2866
2020 Q4	$68	Sell	488 -14	-3%	-$2.27K	﹤0.01%	2851
2020 Q3	$76K	Sell	502 -26	-5%	-$4.24K	﹤0.01%	2674
2020 Q2	$93K	Buy	+528	New	+$88.4K	﹤0.01%	2579
2015 Q4	–	Sell	-1	Closed	-$2K	–	5103
2015 Q3	$2K	Sell	1 -1	-50%	-$1.16K	﹤0.01%	4838
2015 Q2	$1.83K	Sell	2 -31	-94%	-$33.4K	﹤0.01%	4922
2015 Q1	$33.6K	Hold	33	–	–	﹤0.01%	4137
2014 Q4	$110K	Sell	33 -1	-3%	-$3.07K	﹤0.01%	3506
2014 Q3	$99.7K	Hold	34	–	–	﹤0.01%	3558
2014 Q2	$131K	Buy	+34	New	+$128K	﹤0.01%	3370

Other funds holding NBSE

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

JAMONY

Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American International Group's NBSE Position: Q2 2021 in Review

American International Group sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q2 2021, closing a stake of 489 shares — an estimated $72 sold.

American International Group first reported a position in NBSE in Q2 2014 and held it in 10 quarters. The position peaked at $131K in Q2 2014. 57 funds tracked by Wall St. Rank hold NBSE as of Q2 2021.

American International Group reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
American International Group sold 489 NeuBase Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $72.
American International Group first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q2 2014 and held it in 10 quarters.
American International Group's NeuBase Therapeutics, Inc. Common Stock position peaked at $131K in Q2 2014.
57 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q2 2021.

Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.